You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,754,108


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,754,108
Title:Freeze-dried pantoprazole preparation and pantoprazole injection
Abstract: Lyophilized pantoprazole preparations which are obtainable by freeze-drying of an aqueous solution of pantoprazole, ethylenediamine tetraacetic acid and/or a suitable salt thereof, and sodium hydroxide and/or sodium carbonate are disclosed. The preparations have advantageous properties when reconstituted for injection.
Inventor(s): Linder; Rudolf (Constance, DE), Dietrich; Rango (Constance, DE)
Assignee: Takeda, GmbH (Constance, DE)
Application Number:12/010,124
Patent Claim Types:
see list of patent claims
Formulation; Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,754,108

Introduction

The United States Patent 8,754,108, titled "Freeze-dried pantoprazole preparation and pantoprazole injection," is a patent that covers specific methods and compositions related to the preparation and use of pantoprazole, a proton pump inhibitor commonly used to treat gastrointestinal conditions. Here, we will delve into the details of the patent's scope, claims, and the broader patent landscape it operates within.

Patent Overview

Publication Number and Authority The patent, US8754108B2, was granted by the United States Patent and Trademark Office (USPTO) and is categorized under the authority of the United States[4].

Claims Analysis

Independent and Dependent Claims

The patent includes both independent and dependent claims. Independent claims define the invention broadly and are not dependent on other claims, while dependent claims narrow down the invention by adding specific limitations.

  • Independent Claims: These claims outline the core aspects of the invention, such as the composition of the freeze-dried pantoprazole preparation and the method of its preparation.
  • Dependent Claims: These claims build upon the independent claims by adding additional features or limitations, such as specific concentrations of ethylenediamine tetraacetic acid (EDTA) or the use of particular solvents.

Claim Scope and Clarity

The clarity and scope of patent claims are crucial for determining the patent's validity and enforceability. The claims in US8754108B2 are structured to define the invention precisely, avoiding overly broad or unclear language that could lead to disputes.

  • Claim Language: The claims use specific terminology to describe the composition and preparation method, ensuring that the scope of protection is well-defined. For example, the claims specify the use of an aqueous solution of pantoprazole, EDTA, and other components, which helps in distinguishing the invention from prior art[4].

Patent Scope Metrics

Independent Claim Length and Count

Research on patent scope often uses metrics such as independent claim length and count to measure the breadth and clarity of patent claims. While these metrics are more commonly applied to software patents, they can also provide insights into pharmaceutical patents.

  • Independent Claim Length: Longer independent claims may indicate a more detailed and specific definition of the invention, which can help in avoiding broad and vague claims.
  • Independent Claim Count: A higher number of independent claims can suggest a broader scope of protection, but it also increases the complexity of the patent and the potential for overlap with other patents[3].

Practical Applications and Real-World Impact

Use in Medical Treatments

The patent covers the preparation and use of freeze-dried pantoprazole, which is significant in medical treatments. The specific application of this invention includes the creation of an injectable solution, which is crucial for certain medical procedures.

  • Injectable Solution: The patent describes a method for preparing a stable and effective injectable solution of pantoprazole, which enhances its usability in clinical settings. This practical application is a key factor in determining the patent's eligibility and value[4].

Comparison with Recent USPTO Guidance

AI and Software-Related Technologies

Although the US8754108B2 patent does not involve AI or software-related technologies, the recent USPTO guidance on AI patent eligibility provides valuable insights into how practical applications and concrete technological improvements are evaluated.

  • Practical Application: Similar to the USPTO's guidance on AI, the claims in US8754108B2 must demonstrate a practical application of the invention. For instance, the use of the freeze-dried pantoprazole in an injectable solution shows a tangible benefit and improvement in medical technology[1].

Legal and Regulatory Context

Statutory Requirements

The patent must comply with statutory requirements such as those outlined in 35 U.S.C. § 101 (subject matter eligibility) and § 112 (enablement and written description).

  • Enablement: The patent must enable the public to practice the invention, which means the description must be sufficient for a person of ordinary skill in the art to replicate the invention. The detailed description of the preparation method and composition in US8754108B2 ensures that this requirement is met[5].

Patent Landscape and Trends

Pharmaceutical Patents

The pharmaceutical industry is highly competitive, and patents play a critical role in protecting innovations. Trends in pharmaceutical patents often reflect broader debates on patent quality and scope.

  • Patent Quality: The quality of pharmaceutical patents, including those like US8754108B2, is a subject of ongoing debate. Issues such as claim clarity, scope, and the balance between protection and innovation are continually addressed through legal and regulatory updates[3].

Key Takeaways

  • Specific Claim Language: The patent's claims are detailed and specific, ensuring clarity and a well-defined scope of protection.
  • Practical Application: The invention's practical application in medical treatments is a crucial factor in its patent eligibility and value.
  • Statutory Compliance: The patent complies with statutory requirements, including enablement and written description.
  • Industry Trends: The patent reflects broader trends in pharmaceutical patents, emphasizing the importance of clear claims and practical applications.

FAQs

  1. What is the main subject of United States Patent 8,754,108?

    • The main subject is the preparation and use of freeze-dried pantoprazole and pantoprazole injection.
  2. How do the claims in US8754108B2 ensure clarity and scope?

    • The claims use specific terminology to describe the composition and preparation method, avoiding overly broad or unclear language.
  3. What is the significance of the practical application in this patent?

    • The practical application, such as the use in an injectable solution, demonstrates a tangible benefit and improvement in medical technology.
  4. How does this patent comply with statutory requirements?

    • The patent provides a detailed description that enables the public to practice the invention, meeting the requirements of 35 U.S.C. § 112.
  5. What broader trends does this patent reflect in the pharmaceutical industry?

    • It reflects the importance of clear claims, practical applications, and the balance between protection and innovation in pharmaceutical patents.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. Patent Claims Research Dataset - USPTO
  3. Patent Claims and Patent Scope - Hoover Institution
  4. Freeze-dried pantoprazole preparation and pantoprazole injection - Google Patents
  5. Amicus Brief - Supreme Court of the United States

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,754,108

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,754,108

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
00125569Nov 22, 2000

International Family Members for US Patent 8,754,108

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 034277 ⤷  Subscribe
Argentina 092374 ⤷  Subscribe
Austria 381946 ⤷  Subscribe
Australia 1604202 ⤷  Subscribe
Australia 2002216042 ⤷  Subscribe
Bulgaria 107828 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.